<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>Science and Education Publishing</PublisherName>
<JournalTitle>American Journal of Clinical Medicine Research</JournalTitle>
<Issn>2328-403X</Issn>
<Volume>3</Volume>
<Issue>3</Issue>
<PubDate PubStatus="epublish">
<Year>2015</Year>
<Month>06</Month>
<Day>24</Day>
</PubDate>
</Journal>
<ArticleTitle>Evaluation of Alpha (α) and Beta (β) Haemolysin Antibodies Incidence among Blood Group ‘O’ Donors in ATBUTH Bauchi- Nigeria</ArticleTitle>
<FirstPage>42</FirstPage>
<LastPage>44</LastPage>
<Language>EN</Language>
<AuthorList>
<Author>
<FirstName>Obisesan</FirstName>
<LastName>OA</LastName>
</Author>
<Author>
<FirstName>Ogundeko</FirstName>
<LastName>TO</LastName>
<Affiliation>Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, Bingham University, Jos, Nigeria</Affiliation>
</Author>
<Author>
<FirstName>Iheanacho</FirstName>
<LastName>CU</LastName>
</Author>
<Author>
<FirstName>Abdulrazak</FirstName>
<LastName>T</LastName>
</Author>
<Author>
<FirstName>Idyu</FirstName>
<LastName>VC</LastName>
</Author>
<Author>
<FirstName>Idyu</FirstName>
<LastName>II</LastName>
</Author>
<Author>
<FirstName>Isa</FirstName>
<LastName>AH</LastName>
</Author>

</AuthorList>
<ArticleIdList>
<ArticleId IdType="pii">AJCMR2015332</ArticleId>
<ArticleId IdType="doi">10.12691/ajcmr-3-3-2</ArticleId>
</ArticleIdList>
<History>
<PubDate PubStatus="received">
<Year>2015</Year>
<Month>05</Month>
<Day>20</Day>
</PubDate>
<PubDate PubStatus="revised">
<Year>2015</Year>
<Month>06</Month>
<Day>08</Day>
</PubDate>
<PubDate PubStatus="accepted">
<Year>2015</Year>
<Month>06</Month>
<Day>24</Day>
</PubDate>
</History>
<Abstract>Background: Antibodies with haemolytic properties are common within the ABO system. These lytic antibodies are immunoglobulin G (IgG) and in high titres cause haemolysis during blood transfusion. Information on Immunoglobulin types and concentration of ABO haemolysins in Nigerian population is not readily available especially in Northern Nigeria. Methods: Serum samples from 200 males and 25 females O group blood donors were screened for A and B haemolysins. Forty two positive samples (38 males and 4 females) were treated with dithiothretiol (DTT) for characterization of IgG class. Antibody titre was compared with grade of haemolysis. Results: Out of 50 positive samples 42 highly haemolytic serum samples had IgG titres of &gt; or = 64 after treatment with DTT. There was 18.6% occurrence of α and or β haemolysins in blood group O donors also with average titre values ofα-haemolysins (68.2) and β-haemolysins (67).Conclusion: Results showsclear indication of high incidence ofα and β haemolysins among the healthy blood group O donors hence, Haemolysin test was found to be a useful screening test to identify group O donors with high levels of IgG anti A and/or anti B as far as safe blood transfusion is concerned. Aim: The study was determined the incidence of α and β haemolysins in healthy blood group O donors in the Blood Bank Unit of ATBUTH Bauchi.</Abstract>
</Article>
</ArticleSet>
